Olema Pharmaceuticals, Inc.

Ownership Transactions Reported by 20 Insiders

	Insiders	Shares	%	Avg Price	Total $
Buys	2	+1M	51.5%	$6.45	+$6.46M
Sells	6	-941K	48.5%	$7.30	-$6.87M
Net	-4	+60.1K	3.1%		-$414K

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Paradigm Biocapital Advisors LP	10%+ Owner	$174M			Aug 1, 2024
Bain Capital Life Sciences Investors, LLC	10%+ Owner	$24.8M	+$1.73M	+7.5%	Jan 8, 2025
Cyrus Harmon	Director	$7.17M	-$353K	-4.69%	Sep 16, 2025
David C. Myles	Ch. Discov. & Non Clin Dev Off	$6.66M	-$235K	-3.41%	Feb 28, 2025
Graham G. Walmsley	Director	$5.72M	$0	0%	Jun 11, 2025
Shane Kovacs	Ch. Operating & Financial Off.	$5.1M	-$317K	-5.84%	Feb 28, 2025
Bvf Partners L P/Il	Director, Other*	$3.72M			Jun 11, 2025
Sean Bohen	PRESIDENT AND CEO, Director	$2.27M	-$986K	-30.3%	Feb 28, 2025
Naseem Zojwalla	Chief Medical Officer	$631K	-$250K	-28.4%	Feb 28, 2025
Kinney Horn	Chief Business Officer	$17.3K			Feb 1, 2023
J. Scott Garland	Director				Jun 11, 2025
Sandra Horning	Director				Jun 11, 2025
Gorjan Hrustanovic	Director				Jun 11, 2025
Peter J. Kushner	Chief Scientific Officer				Feb 1, 2022
Yi Larson	Director				Jun 11, 2025
Andrew Rappaport	Director				Jun 11, 2025
Shawnte Mitchell	Chief Legal Officer				Feb 28, 2025
John B. Moriarty	EVP, Ch. Legal Officer & Sec.				Feb 1, 2023
Ian T. Clark	Director				Jun 11, 2025
Cynthia M. Butitta	Director				Jun 11, 2025

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.